Inkjet-BioAM

The inkjet-bioAM project focuses on digitalizing the production of medical and pharmaceutical products by using industrial multi-material inkjet printing processes.

The main goal is to integrate inkjet technology into the healthcare value chain, aiming to improve patient care and ensure the sustainability of the healthcare system. The project is developing three demonstrator pilot lines: Bioscaffolds, Biosensors, and Personal Medication. It is a consortium funded by the EU's I3 (Interregional Innovation Investment) Instrument.

Use Case 2: Biosensors

This use case focuses on applying multi-material inkjet printing technology for the smart manufacturing of biosensors.

Primary Goal: To develop an industrial pilot line capable of producing cost-effective, high-performance, and personalized biosensors.

Anticipated Focus Areas:

• Technology: Utilizing inkjet printing—an additive, fast, and low-waste method—to precisely deposit ultra-thin functional layers onto various substrates.

• Materials: Likely involves using specific "inks" containing nanomaterials (nanoparticles, carbon nanotubes, polymeric composites) and biorecognition elements (antibodies, enzymes) to form the sensor's active components.

• Target Applications: The sensors are designed for the rapid and accurate detection of specific biomarkers (proteins, metabolites, hormones) for Point-of-Care (PoC) diagnostics or environmental monitoring.

• Benefit: The main advantages are accelerating manufacturing time, reducing material costs, and enabling the customization of sensor design based on individual patient or application requirements.